Gold tier: mechanically validated evidence, with its primary source.
238 evidence items · page 9 / 10
6.13 %Hepatitis B was diagnosed in 6.13% of young HIV patients aged 15 to 24 years at a major hospital in Sierra Leone.
Sierra Leonehépatite B · VIH/sidapublished 2023Prevalence and factors associated with advanced HIV disease among young people aged 15 - 2europe_pmcdocument of 8 observationsDOI 10.1101/2023.11.07.23296880
74 testsMean quarterly HBV tests were 74 ± 16 during April–June in Freetown, Sierra Leone.
Sierra Leonehépatite Bobserved April-Junepublished 2023Impact of COVID-19 on Hepatitis B Screening in Sierra Leone: Insights from a Community Phaeurope_pmcdocument of 8 observationsDOI 10.1101/2023.05.24.23290418
33.4 %The prevalence of hypertension was 33.4% among males and 37.4% among females in Sierra Leone.
Sierra Leonehypertension artériellepublished 2023Sex-and-gender differences in cardiovascular risk factors and their correlates among adulteurope_pmcdocument of 5 observations
80 %Headache was present in 80% of patients with Ebola virus disease at presentation.
Sierra Leonemaladie à virus Ebolapublished 2014The New England journal of medicineeurope_pmcdocument of 14 observations
700 deathsLe nombre de décès liés à l'Ebola en Sierra Leone est passé de près de 700 décès en octobre 2014 à près de 4 000 décès en avril 2015.
Sierra Leonemaladie à virus Ebolaobserved octobre 2014HAL · Unilimdocument of 82 observations
8.2 %The cumulative incidence of surgical site infections (SSIs) was 8.2%.
Sierra Leonesurgical site infections (SSIs)published 2022Therapeutic advances in infectious diseaseeurope_pmcdocument of 6 observations
11.8 %The prevalence of metabolic syndrome in Freetown, Sierra Leone was 11.8% using the NCEP ATP III criteria among 2,394 selected adults.
Sierra Leonesyndrome métaboliqueobserved 2019 to 2022published 2023Prevalence and correlates of Metabolic Syndrome among adults in Freetown, Sierra Leone: A europe_pmcDOI 10.1101/2023.06.26.23291915
38.4 %Of the 1369 people diagnosed with HIV, 526 (38.4%) were linked to care.
Sierra LeoneVIH/sidapublished 2024AIDS and behavioreurope_pmcdocument of 7 observations
55,257 dosesThe median monthly uptake of total IPTp was 55,257 during COVID-19.
Sierra Leonepaludismepublished 2025Impact of the COVID-19 pandemic on the uptake of intermittent sulphadoxine-pyrimethamine feurope_pmcdocument of 5 observations
27 %HBV screening increased by 27% in the first year after COVID-19 in Freetown, Sierra Leone.
Sierra Leonehépatite Bpublished 2023Impact of COVID-19 on Hepatitis B Screening in Sierra Leone: Insights from a Community Phaeurope_pmcdocument of 8 observationsDOI 10.1101/2023.05.24.23290418
7.34 aORTuberculosis independently predicted diabetes/prediabetes among people living with HIV, with an adjusted odds ratio of 7.34.
Sierra Leonediabetes/prediabetes · tuberculosepublished 2022Journal of clinical medicineeurope_pmcdocument of 9 observations
31.2 %C-reactive protein was elevated in 31.2% of the articles on COVID-19 patients with sepsis or septic shock.
Sierra LeoneCOVID-19 · sepsis · septic shockpublished 2020Sepsis and septic shock in COVID-19: a scoping review of the research dataeurope_pmcdocument of 17 observationsDOI 10.21203/rs.3.rs-30474/v1
95.2 %The largest reduction in HIV testing in 2020 occurred among children under 15, with a 95.2% decrease.
Sierra LeoneVIH/sidaobserved 2020published 2024AIDS and behavioreurope_pmcdocument of 7 observations
3.8 %Among 23 patients with chronic pulmonary aspergillosis (CPA), 2 (3.8%) had current TB and 18 (17.3%) had past TB.
Sierra Leonepulmonary aspergillosis · tuberculoseobserved November 2021 to July 2022published 2023PLoS neglected tropical diseaseseurope_pmcdocument of 9 observations
60 %Dizziness was present in 60% of patients with Ebola virus disease at presentation.
Sierra Leonemaladie à virus Ebolapublished 2014The New England journal of medicineeurope_pmcdocument of 14 observations
72.2 %Among 306 adult participants in Freetown, Sierra Leone, 72.2% stated they would receive the HBV vaccine if offered.
Sierra Leonehépatite Bpublished 2023Healthcare (Basel, Switzerland)europe_pmcdocument of 5 observationsDOI 10.3390/healthcare11020177
58 %Among suspected COVID-19 patients, 58% of the antibiotics prescribed belonged to the 'WATCH' category.
Sierra LeoneCOVID-19published 2022International journal of environmental research and public healtheurope_pmcdocument of 3 observationsDOI 10.3390/ijerph19074005
5.4 %The lowest mortality among study participants with COVID-19 and sepsis or septic shock was 5.4%.
Sierra LeoneCOVID-19 · sepsis · septic shockpublished 2020Sepsis and septic shock in COVID-19: a scoping review of the research dataeurope_pmcdocument of 17 observationsDOI 10.21203/rs.3.rs-30474/v1
5.9 %Among pregnant women in Sierra Leone, Y181C/V/I was found in 5.9% (n = 2/34) of cases.
Sierra LeoneVIH/sidapublished 2021Geneseurope_pmcdocument of 21 observationsDOI 10.3390/genes12091314
2 timesThe true epidemic size of mpox in Sierra Leone was estimated to be nearly double the official case counts.
Sierra Leonempoxpublished 2026Nature medicineeurope_pmcdocument of 4 observations
Childhood vaccination coverage against hepatitis B virus is suboptimal in Sierra Leone, Liberia, and Guinea.
Guinée · Liberia · Sierra Leonehépatite Bpublished 2023Epidemiology and infectioneurope_pmcdocument of 3 observationsDOI 10.1017/s0950268823001735
5,000 casesSierra Leone had more than 5,000 confirmed mpox cases by August 2025.
Sierra Leonempoxobserved Augustpublished 2026Nature medicineeurope_pmcdocument of 4 observations
68.5 %The proportion of drug-resistant TB cases that completed treatment was 68.5% in the post-COVID-19 period.
Sierra Leonedrug-resistant TBobserved post-COVID-19published 2025Effect of the COVID-19 pandemic on drug-resistant tuberculosis treatment outcomes at a nateurope_pmcdocument of 9 observations
51 %Diarrhea was present in 51% of patients with Ebola virus disease at presentation.
Sierra Leonemaladie à virus Ebolapublished 2014The New England journal of medicineeurope_pmcdocument of 14 observations
36.1 %Only 753 (36.1%) HIV-positive women had documented facility-based delivery.
Sierra LeoneVIH/sidapublished 2026PLOS global public healtheurope_pmcdocument of 6 observations
Every row leads to its source document. The figure shown counts the VALIDATED observations it carries, never the extracted ones: the two differ on most documents. The exact source excerpt is not published, due to copyright constraints.